InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: None

Tuesday, 06/01/2021 10:47:36 AM

Tuesday, June 01, 2021 10:47:36 AM

Post# of 232694
Problematic PR


1. No mention of quantity sold.

2. No mention of pricing.

3. No mention of Government or Regulator approving sale under compassionate use.

4. Touting of non-clinical data, again, as basis for approval.


With Nader facing a proxy battle I have no doubt there will be other PRs like this. Sounding great, but extremely shallow on details. If something comes up to contradict the PR expect a crash.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News